MMSI Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
418.8M
+9.7%
381.9M
-3.1%
393.9M
+2.5%
384.2M
+0.4%
382.5M
Cost of Revenue
203.7M
+3.3%
197.1M
-0.8%
198.6M
+0.4%
197.7M
-0.1%
198.0M
Gross Profit
215.2M
+16.4%
184.8M
-5.4%
195.4M
+4.8%
186.4M
+1.0%
184.5M
Operating Expenses
154.8M
+10.0%
140.6M
-0.4%
141.2M
-1.8%
143.8M
+4.5%
137.6M
R&D
25.4M
+12.3%
22.6M
-14.8%
26.5M
+10.7%
24.0M
-1.6%
24.4M
SG&A
129.2M
+9.3%
118.2M
+2.9%
114.8M
-4.1%
119.8M
+5.9%
113.1M
Operating Income
60.4M
+36.8%
44.2M
-18.5%
54.2M
+27.2%
42.6M
-9.1%
46.9M
EBITDA
91.4M
+22.5%
74.7M
-12.9%
85.7M
+16.0%
73.9M
-5.1%
77.9M
Net Income
38.8M
-5.3%
41.0M
+7.9%
38.0M
+36.9%
27.8M
-14.8%
32.6M
EPS (Basic)
$0.65
-5.8%
$0.69
+7.8%
$0.64
+36.2%
$0.47
-14.5%
$0.55
EPS (Diluted)
$0.65
-4.4%
$0.68
+7.9%
$0.63
+37.0%
$0.46
-14.8%
$0.54
Shares (Diluted)
60.0M
-0.0%
60.0M
-0.0%
60.0M
+0.2%
59.9M
-1.1%
60.6M
Merit Medical Systems (MMSI) โ€” Financials